Welcome to our dedicated page for AMERICAN VANGUARD SEC filings (Ticker: AVD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
American Vanguard Corporation's SEC filings document the formal disclosures of a NYSE-listed specialty agriculture products company and its AMVAC Chemical Corporation operating subsidiary. Recent Form 8-K reports cover operating results, earnings-call materials, Regulation FD disclosures and material credit arrangements, including term-loan and revolving-credit amendments tied to the company's capital structure and working-capital needs.
Proxy and annual-meeting filings address board elections, director composition, auditor ratification, executive compensation and shareholder voting matters. The filings also identify the company's common stock, par value, exchange listing and governance actions related to board size and committee-level oversight.
American Vanguard Corporation reported 2025 net sales of $515.1 million and a net loss of $49.9 million, a substantial improvement from a $126.3 million loss in 2024. Gross margin rose to 29% from 22% as cost of sales fell 14%, helped by lower inventory write-downs and better procurement.
U.S. net sales were roughly flat at $311.7 million, with weaker crop sales offset by stronger non‑crop revenue, including $11.25 million from a technology licensing deal. International sales declined 14% to $203.4 million, mainly from drought in Australia and high channel inventories in Mexico.
Operating expenses fell 21% to $175.9 million, driven by lower transformation spending, reduced research and regulatory costs, and smaller impairment charges, partly offset by $9.7 million in product liability claims. Average debt remained high at $194.7 million, with net interest expense of $18.5 million at an effective 9.5% rate, and year‑end senior credit facility borrowings of $174.0 million.
American Vanguard Corp received an amended Schedule 13G showing that Topline Capital Management, Topline Capital Partners and Collin McBirney now report beneficial ownership of 0 shares, or 0% of the common stock, as of 12/31/2025.
The filers state they previously acquired and held the securities in the ordinary course of business and not to change or influence control of American Vanguard, other than activities solely in connection with a director nomination process.
American Vanguard Corp. reported that Chief Executive Officer Douglas Kaye acquired additional company stock through its employee stock purchase plan. On 01/29/2026, he obtained 4,790 shares of common stock at $3.26 per share, funded via payroll deductions over the July 1, 2025 to December 31, 2025 period.
Following this transaction, Kaye beneficially owned 295,251 shares of American Vanguard common stock in total.
American Vanguard Corp. director reports share distribution from investment fund
A director of American Vanguard Corp. (AVD) reported receiving 47,281 shares of common stock on 11/26/2025. This was recorded on a Form 4 as an acquisition at a reported price of $0 per share, reflecting that it was not a market purchase.
After this transaction, the director beneficially owns 126,705 shares of American Vanguard common stock in direct ownership. According to the explanation, the shares came from a pro‑rata distribution by a private investment fund controlled by Cruiser Capital, in which the reporting person was a non‑managing member. The distribution occurred in connection with the fund’s dissolution and did not involve any purchase, sale, or payment of consideration by the director.
American Vanguard Corp director updates share holdings after fund distribution. A fund managed by Cruiser Capital, where the reporting person is Managing Member, distributed an aggregate of 231,404 American Vanguard common shares to its members on a pro rata basis for no consideration on 11/26/2025. As part of this, 217,503 shares previously attributed to the fund are no longer counted as shares in which Cruiser Capital has a beneficial or pecuniary interest.
Within that total distribution, Cruiser Capital received 13,901 shares, which continue to be included in the reporting person’s holdings. Following the transaction, the reporting person reports 34,411 American Vanguard shares held directly and 571,781 shares held indirectly through Cruiser Capital’s managed funds and separately managed accounts, over which he may be deemed to share voting and dispositive power.
American Vanguard Corporation filed an 8-K reporting that it issued a press release with unaudited financial results for the three-month period ended September 30, 2025 and held its previously announced earnings call the same day. The press release (Exhibit 99.1) and call transcript (Exhibit 99.2) are furnished.
The company also updated its full-year 2024 non-GAAP metric: final Adjusted EBITDA was $39.1 million, compared with the preliminary figure of approximately $42 million disclosed on March 14, 2025. The company defines Adjusted EBITDA as EBITDA further adjusted for items management views as not reflective of underlying operations; in 2024 this included certain non-recurring expenses and profit on sale of an asset not held for sale. The metric aligns with the company’s current credit facility.
The furnished materials under Items 2.02 and 7.01 are not deemed "filed" and are not incorporated by reference unless expressly stated.
American Vanguard (AVD) reported Q3 2025 results with net sales of $119.3 million, up 1% year over year. Gross profit rose to $34.2 million and gross margin expanded to 29%. Operating loss narrowed to $6.5 million from $28.4 million, and net loss improved to $12.4 million, or $0.43 per share.
U.S. sales increased 8% while international declined 6%. Cost controls and lower freight helped margins, partly offset by a $7.0 million product liability charge tied to an ornamental insecticide. For the first nine months, sales were $364.4 million (down 5%), gross margin was 29% (up from 26%), and operating loss narrowed to $6.4 million from $31.5 million.
Cash used in operations was $27.1 million year‑to‑date. Long‑term debt was $182.3 million with a 8.01% rate at September 30, 2025. The revolving credit facility maturity was extended to December 31, 2026 with staged commitment reductions, and the company reported capacity to borrow up to $46.9 million as of quarter‑end. Under the amended agreement, the company is currently prevented from paying cash dividends.
American Vanguard Corp (AVD): The Vanguard Group filed a Schedule 13G reporting beneficial ownership of 1,538,471 shares of AVD common stock, representing 5.41% of the class as of 09/30/2025.
Vanguard reports 0 sole voting power and 168,205 shared voting power. It has 1,360,046 shares with sole dispositive power and 178,425 with shared dispositive power. The filing states the securities are held in the ordinary course of business, and Vanguard’s clients have rights to dividends or sale proceeds; no single client has more than 5%.
Peter Eilers, a Managing Director at AMVAC Netherlands BV who is an officer and director of American Vanguard Corp (AVD), reported a sale of 6,000 shares of AVD common stock on 09/04/2025 at $5.35 per share to satisfy an income tax liability. After the transaction he beneficially owns 32,177 shares, held directly. The Form 4 discloses the transaction date, price, and a brief explanation that the sale was to cover taxes; no derivatives or other transactions were reported. The filing is routine disclosure of insider selling and does not include additional context about future transactions or company performance.
American Vanguard Corporation (AVD) filed a Form 144 to notify a proposed sale of securities under Rule 144. The notice reports 6,000 shares of common stock offered for sale through Merrill Lynch, Newport Beach, with an aggregate market value of $32,078.56 based on the filing. The proposed sale date is 09/04/2025 on the NYSE.
The shares were acquired as a performance award from American Vanguard Corp on 01/01/2020 and no securities of the issuer have been reported sold by the seller in the past three months. The filer affirms no undisclosed material adverse information.